• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名食管鳞状细胞癌患者经根治性内镜黏膜下剥离术后出现反复淋巴结复发,病理判断为pT1a-LPM:病例报告及文献复习

Repeated lymph-node recurrences after radical endoscopic submucosal dissection in a patient of esophageal squamous cell carcinoma, judged as pT1a-LPM: a case report and literature review.

作者信息

Hirose Kosuke, Sadanaga Noriaki, Kato Seiya, Yoshimura Daisuke, Sokabe Yuta, Sasaki Shun, Honbo Takuya, Tsuda Yasuo, Matsuura Hiroshi, Mimori Koshi

机构信息

Department of Surgery, Kyushu University Beppu Hospital, Tsurumibara 4546, Beppu-Shi, Oita, 874-0838, Japan.

Department of Surgery, Saiseikai Fukuoka General Hospital, Tenjin 1-3-46, Chuo-Ku, Fukuoka-Shi, Fukuoka, 810-0001, Japan.

出版信息

Clin J Gastroenterol. 2025 Aug 21. doi: 10.1007/s12328-025-02206-y.

DOI:10.1007/s12328-025-02206-y
PMID:40835809
Abstract

Esophageal squamous cell carcinoma confined to the depth of the T1a-epithelium and lamina propria mucosa rarely exhibits lymph node and distant organ metastases; therefore, the recommended therapy for such cases is endoscopic resection. Furthermore, once esophageal squamous cell carcinoma recurs after curative treatment, including endoscopic mucosal dissection, a unified treatment method cannot be established, because recurrence patterns vary from case to case. Herein, we present an unusual case of metachronous locoregional and subclavian lymph-node recurrence following repeated radical endoscopic submucosal dissection of the superficial esophageal squamous cell carcinoma judged as T1a-LPM with deep subepithelial stromal invasion. The patient was treated using a multidisciplinary approach, leading to a cancer-free status. Although recurrent lymph-node metastasis after curative endoscopic submucosal dissection for pT1a-LPM esophageal squamous cell carcinoma is rare, it is possible. A comprehensive and detailed analysis of the risk factors of recurrence after endoscopic resection for pT1a-LPM cases is required, and appropriate follow-up strategies and stratified adjuvant therapies should be selected for high-risk patients.

摘要

局限于T1a期上皮层和黏膜固有层的食管鳞状细胞癌很少出现淋巴结和远处器官转移;因此,此类病例推荐的治疗方法是内镜下切除。此外,包括内镜黏膜下剥离术在内的根治性治疗后,一旦食管鳞状细胞癌复发,由于复发模式因病例而异,无法确立统一的治疗方法。在此,我们报告一例不同时间发生的局部区域和锁骨下淋巴结复发的罕见病例,该病例为经多次根治性内镜黏膜下剥离术治疗的浅表食管鳞状细胞癌,最初判定为T1a-LPM(黏膜固有层)伴深层上皮下间质浸润。该患者采用多学科方法进行治疗,最终实现无癌状态。尽管pT1a-LPM期食管鳞状细胞癌经根治性内镜黏膜下剥离术后出现复发性淋巴结转移的情况罕见,但仍有可能发生。对于pT1a-LPM病例,需要对内镜切除术后复发的危险因素进行全面、详细的分析,并应为高危患者选择合适的随访策略和分层辅助治疗。

相似文献

1
Repeated lymph-node recurrences after radical endoscopic submucosal dissection in a patient of esophageal squamous cell carcinoma, judged as pT1a-LPM: a case report and literature review.一名食管鳞状细胞癌患者经根治性内镜黏膜下剥离术后出现反复淋巴结复发,病理判断为pT1a-LPM:病例报告及文献复习
Clin J Gastroenterol. 2025 Aug 21. doi: 10.1007/s12328-025-02206-y.
2
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.内镜及手术切除 T1a/T1b 食管肿瘤:系统评价。
World J Gastroenterol. 2013 Mar 7;19(9):1424-37. doi: 10.3748/wjg.v19.i9.1424.
3
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.内镜超声检查(EUS)对原发性胃癌术前局部区域分期的诊断准确性。
Cochrane Database Syst Rev. 2015 Feb 6;2015(2):CD009944. doi: 10.1002/14651858.CD009944.pub2.
4
Lateral lymph node dissection combined with endoscopic submucosal dissection for early rectal cancer complicated with ulcerative colitis: A case report.侧方淋巴结清扫联合内镜下黏膜下剥离术治疗合并溃疡性结肠炎的早期直肠癌:1例病例报告
Medicine (Baltimore). 2025 Jul 4;104(27):e43160. doi: 10.1097/MD.0000000000043160.
5
Investigating tumor-infiltrating lymphocytes as predictors of lymph node metastasis in deep submucosal invasive esophageal squamous cell carcinoma: a retrospective cross-sectional study.探讨肿瘤浸润淋巴细胞作为深层黏膜下浸润性食管鳞状细胞癌淋巴结转移预测指标的研究:一项回顾性横断面研究
J Gastroenterol. 2025 Jul 25. doi: 10.1007/s00535-025-02286-0.
6
Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement.内镜黏膜下剥离术治疗未侵犯黏膜下固有肌层且无淋巴管浸润的食管鳞状细胞癌的随访观察的临床结局。
Dig Dis Sci. 2023 Sep;68(9):3679-3687. doi: 10.1007/s10620-023-08034-9. Epub 2023 Jul 20.
7
Prognosis for local radical treatment in patients with esophageal squamous cell carcinoma with low-risk oligometastatic recurrence after curative resection: a retrospective cohort study.食管癌根治性切除术后低风险寡转移复发的食管鳞状细胞癌患者局部根治性治疗的预后:一项回顾性队列研究
J Gastrointest Oncol. 2024 Jun 30;15(3):807-817. doi: 10.21037/jgo-24-205. Epub 2024 Jun 17.
8
Treatment Outcomes and Patterns of Disease Recurrence of Patients with Carcinoma of the Buccal Mucosa.颊黏膜癌患者的治疗结果与疾病复发模式
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5209-5220. doi: 10.1007/s12070-024-04948-6. Epub 2024 Aug 30.
9
[Application research of endoscopic-laparoscopic regional gastric resection combined with sentinel lymph node basin dissection in patients with early gastric cancer].内镜-腹腔镜区域胃切除术联合前哨淋巴结清扫在早期胃癌患者中的应用研究
Zhonghua Wai Ke Za Zhi. 2025 Jul 1;63(7):587-596. doi: 10.3760/cma.j.cn112139-20250117-00034.
10
Risk of Metastasis and Local Residual Cancer After Non-Curative Endoscopic Submucosal Dissection for Esophageal Cancer.食管癌非根治性内镜下黏膜下剥离术后的转移风险及局部残留癌风险
Dig Endosc. 2025 Jul 6. doi: 10.1111/den.15082.

本文引用的文献

1
Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma.循环肿瘤 DNA 动力学作为局部晚期和转移性食管鳞癌的预后标志物。
JAMA Surg. 2023 Nov 1;158(11):1141-1150. doi: 10.1001/jamasurg.2023.4395.
2
The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma.早期术后复发的食管鳞癌患者各治疗方法的疗效和预后。
Surg Today. 2024 Jan;54(1):53-63. doi: 10.1007/s00595-023-02702-z. Epub 2023 May 25.
3
Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2.
日本食管癌学会编辑的《2022年食管癌诊疗指南》:第2部分
Esophagus. 2023 Jul;20(3):373-389. doi: 10.1007/s10388-023-00994-1. Epub 2023 Mar 30.
4
Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.日本食管癌学会编辑的《2022年食管癌诊疗指南》:第1部分。
Esophagus. 2023 Jul;20(3):343-372. doi: 10.1007/s10388-023-00993-2. Epub 2023 Mar 18.
5
Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma.治疗期间食管鳞癌患者循环肿瘤 DNA 的肿瘤负担监测。
Ann Surg Oncol. 2023 Jun;30(6):3747-3756. doi: 10.1245/s10434-023-13194-z. Epub 2023 Feb 14.
6
Risk factors of lymph node metastasis or lymphovascular invasion for superficial esophageal squamous cell carcinoma: A practical and effective predictive nomogram based on a cancer hospital data.食管浅表鳞状细胞癌淋巴结转移或淋巴管侵犯的危险因素:基于某癌症医院数据的实用且有效的预测列线图
Front Med (Lausanne). 2022 Nov 17;9:1038097. doi: 10.3389/fmed.2022.1038097. eCollection 2022.
7
Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma.局部晚期食管鳞癌放疗后监测循环肿瘤 DNA 的预后价值。
Clin Transl Med. 2022 Nov;12(11):e1116. doi: 10.1002/ctm2.1116.
8
Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma.血浆循环肿瘤DNA测序可预测可切除食管鳞状细胞癌的微小残留病。
Front Oncol. 2021 May 20;11:616209. doi: 10.3389/fonc.2021.616209. eCollection 2021.
9
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.纳武利尤单抗辅助治疗食管或胃食管结合部癌。
N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125.
10
Oligometastases After Curative Esophagectomy Are Not One Size Fits All.根治性食管切除术后寡转移并非一刀切。
Ann Thorac Surg. 2021 Dec;112(6):1775-1781. doi: 10.1016/j.athoracsur.2021.03.002. Epub 2021 Mar 6.